Cost Saving Analysis of Pharmacists’ Intervention in Chemotherapy Preparation Unit of Cancer Institute, Imam Khomeini Hospital,1396-97
- سال انتشار: 1398
- محل انتشار: دومین کنگره اروپایی آسیایی فارماکواپیدمیولوژی
- کد COI اختصاصی: AECPMED02_037
- زبان مقاله: انگلیسی
- تعداد مشاهده: 500
نویسندگان
Tehran University of Medical Sciences International Campus-School of Pharmacy
Tehran University of Medical Sciences International Campus-School of Pharmacy
Tehran University of Medical Sciences International Campus-School of Pharmacy
Tehran University of Medical Sciences International Campus-School of Pharmacy
Tehran University of Medical Sciences International Campus-School of Pharmacy
چکیده
OBJECTIVES: Cancer is one of the major causes of mortality and represents a significant burden of disease. Due to the complexity of chemotherapy regimens, medication errors can occur at any point from prescribing to administration. Today, pharmacists play an important role in rationalizing consumption and prescription of medicines for patients undergoing chemotherapy. Intervention of pharmacist, as one of the last members of the treatment team, can reduce Adverse Drug Events (ADEs) and ultimately save costs. This study estimated the cost– benefit ratio of pharmacist interventions over a year in chemotherapy preparation unit of a referral hospital in Iran in which annually about 10,000 cancer patients receive inpatient and outpatient care. METHODS: Pharmacist intervention records from Sep 2017 to Aug 2018 collected in a standard checklist in Cancer Institute, Tehran University of Medical Sciences, Iran. The clinical significance of interventions was rated by one oncologist and one clinical pharmacist according to Common Terminology Criteria for Adverse Event (CTCAE). Benefit was estimated through bothcost avoidance based on the potential to avoid an ADE and cost savings related to reducing discarded products. Cost was estimated from the pharmacists salary corresponding to the time spent in reviewing chemotherapy prescriptions. Finally, cost-benefit analysis was conducted.RESULTS: Among 18,450 cancer chemotherapy prescriptions, 559 interventions were applied. Most cases of interventions were related to dosage adjustment of the prescribed dosage (36.4%). 78% of the interventions were considered as clinically more than significant. The cost-benefitanalysis showed a clear cost benefit with a cost-benefit ratio of [2.4-18.2]:1 (depends on the significance of the interventions). CONCLUSION: Positive impact of pharmacists’ interventions on the clinical and economic outcome of chemotherapy drugs was clearly demonstrated in thisstudy. This service could reduce medication errors, preventable ADEs, and costs of both medications and potential ADEsکلیدواژه ها
Pharmacists’ interventions, pharmaceutical care services, , chemotherapy drugs, cost-benefit analysisمقالات مرتبط جدید
- تاثیر پرایمینگ بذر بر رشد گیاهچه ماش سبز در سطوح مختلف تنشاسمزی
- استفاده از پوشش های خوراکی ضد میکروبی حاوی اسانس و عصاره هایگیاهی در افزایش زمان ماندگاری گوشت گاو تازه
- جنبه های اقتصادی تولید و تجارت زعفران در ایران
- کاهش قند خون با جایگزینی استویا در کیک فراسودمند دیابتی
- بررسی اثربخشی مواد گیاهی در لوازم آرایشی ضد چین و چروک
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.